MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The effectiveness of deep brain stimulation in dystonia: A patient-centered approach

    H. Eggink, R. Toonen, J. van Zijl, M. van Egmond, A. Bartels, R. Brandsma, MF. Contarino, K. Peall, J M. van Dijk, DLM. Oterdoom, M. Beudel, M. Tijssen (Groningen, Netherlands)

    Objective: To systematically evaluate the effectiveness of deep brain stimulation of the Globus Pallidus internus (GPi-DBS) in dystonia on pre-operatively set functional priorities in daily…
  • 2018 International Congress

    Weight loss in STN DBS in Parkinson’s Disease? Long-term outcome of a prospective cohort at 5 years

    D. Chan, C. Chan, A. Chan, C. Lau, C. Zhu, W. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To determine the long-term weight changes in Parkinson’s Disease (PD) after Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) treatment. Background: It is well-established that…
  • 2018 International Congress

    Directional deep brain stimulation in Parkinson’s disease guided by local field potentials

    F. Alonso-Frech, C. Fernandez-Garcia, M. Monge, M.J. Catalan Alonso, G. Foffani (Madrid, Spain)

    Objective: Implementation of directional stimulation of subthalamic nucleus with segmented leads guided by local field potential (LFP) recordings in order to personalize DBS parameters, optimize…
  • 2018 International Congress

    Evaluation of apathy before and after subthalamic nucleus deep brain stimulation therapy in advanced Parkinson’s disease patients

    S. Caferova, O. Gönül, D. Gunal (Istanbul, Turkey)

    Objective: Deep brain stimulation (DBS) has been approved to relieve the motor symptoms of Parkinson's disease (PD) patients when the optimal pharmachologic treatment is unsatisfactory.…
  • 2018 International Congress

    Impact of Disease Duration and Anatomical Target on Health Related QoL in Patients Receiving DBS: Results from the Product Surveillance Registry

    M. Schiess, S. Falowski, S. Palfi, J. Azulay, A. Lopez-Rios, L. Defebvre, J. Espinoza, K. Sandberg, B. Van Dorn, T. Weaver, P. Konrad, J. Krauss (Houston, TX, USA)

    Objective: Summarize change in quality of life (QoL) by comparing scores from the EuroQuol-five domain questionnaire, five level response version (EQ-5D-5L) summary index obtained at…
  • 2018 International Congress

    Malignant neuroleptic syndrome following a sudden deep brain stimulation battery drain: Report of two cases

    O. Yilmaz Kusbeci, A. Acarer, Y. Unsal, Z. Colakoglu, R. Bilgin (Izmir, Turkey)

    Objective: In this case report we present two cases of NMS associated with sudden drain of DBS batteries (37 years old Caucasian woman and 42…
  • 2018 International Congress

    Tics in Wilson’s Disease and Review of the Literature

    AY. Yılmaz, M. Kuzu Kumcu, MC. Akbostancı (Ankara, Turkey)

    Objective: We report a case with tics in a patient with Wilson’s Disease (WD). Background: Wilson’s disease is a genetic disorder of copper metabolism, leading…
  • 2018 International Congress

    Loss of paraplegin drives spasticity rather than ataxia in SPG7: A European cohort analysis of 238 patients

    G. Coarelli, R. Schule, B. vande Warrenburg, P. de Jonghe, C. Ewenczyk, A. Martinuzzi, M. Synofzik, E. Hamer, J. Baets, M. Anheim, L. Schöls, T. Deconinck, B. Fontaine, T. Klockgether, MG. D'Angelo, ML. Monin, P. Charles, MT. Bassi, T. Klopstock, E. Ollagnon-Roman, C. Kamm, M. Papin, CS. Davoine, G. Banneau, S. Tezenasdu Montcel, D. Seilhean, A. Brice, C. Duyckaerts, G. Stevanin, A. Durr (Paris, France)

    Objective: The aim of this work was to delineate the clinical phenotype of SPG7 patients, integrating genetic data and follow-up examinations, taking advantage of a…
  • 2018 International Congress

    Cerebellar Ataxia as a Manifestation of Hashimoto Encephalopathy

    S. Thakolwiboon, D. Ruthirago, V. Senanarong (Lubbock, TX, USA)

    Objective: To characterize the clinical, laboratory and radiologic findings as well as prognosis of Hashimoto encephalopathy (HE) presenting with cerebellar ataxia Background: HE is a…
  • 2018 International Congress

    Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38

    D. Perani, L. Orsi, C. Costanzi, M. Ferrero, A. Zoppo, F. Tempia, D. Caruso, M. Grassi, A. Padovani, A. Brusco, B. Borroni (Brescia, Italy)

    Objective: To evaluate the safety and efficacy of docosahexaenoic acid supplementation in patients with spinocerebellar ataxia 38 (SCA 38), on clinical symptoms and changes of…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley